Cytokine mRNA gene expression in active and nonactive pulmonary sarcoidosis

Sarcoidosis is a multisystem granulomatous disease associated with the expansion and activation of CD4+ T-lymphocytes and macrophages. To investigate the immunopathology of active and nonactive pulmonary sarcoidosis, we have examined the expression of cytokine gene transcripts in bronchoalveolar lavage cells from 15 patients with active pulmonary sarcoidosis, eight patients with non-active pulmonary sarcoidosis, and nine normal controls. Using in situ hybridization, the percentage of cells expressing messenger ribonucleic acid (mRNA) for interleukin (IL)-1 beta, IL-2, IL-3, IL-4, IL-5, IL-6, IL-10, IL-12 and interferon-gamma (IFN-gamma) were compared in the groups studied. In individuals with active sarcoidosis, there were significantly greater proportions of cells expressing mRNA for IL-2, IL-10, IL-12 and IFN-gamma than in subjects with nonactive disease and normal controls (p < 0.01). There was no significant difference in the percentage of positive cells expressing IL-10 and IL-12 mRNA in the nonactive group compared to the normal controls (p > 0.05). No significant differences in the percentages of IL-3, IL-4 and IL-5 mRNA positive cells were observed between active and nonactive sarcoidosis patients and normal controls (p > 0.05). These results demonstrate that there is a preferential expression of T-helper type 1 cytokines in pulmonary sarcoidosis, and that cytokines related to macrophage activation are the most prominent. In addition, these data implicate an elevated expression of interleukin-2, -10 and -12 and interferon-gamma in active compared to nonactive sarcoidosis.

This article has been cited by other articles:

				Y. Komohara, J. Hirahara, T. Horikawa, K. Kawamura, E. Kiyota, N. Sakashita, N. Araki, and M. Takeya AM-3K, an Anti-macrophage Antibody, Recognizes CD163, a Molecule Associated with an Anti-inflammatory Macrophage Phenotype J. Histochem. Cytochem., July 1, 2006; 54(7): 763 - 771. [Abstract] [Full Text] [PDF]

				F. Idali, M. Wiken, J. Wahlstrom, H. Mellstedt, A. Eklund, H. Rabbani, and J. Grunewald Reduced Th1 response in the lungs of HLA-DRB1*0301 patients with pulmonary sarcoidosis. Eur. Respir. J., March 1, 2006; 27(3): 451 - 459. [Abstract] [Full Text] [PDF]

				H. Dai, J. Guzman, B. Chen, and U. Costabel Production of Soluble Tumor Necrosis Factor Receptors and Tumor Necrosis Factor-{alpha} by Alveolar Macrophages in Sarcoidosis and Extrinsic Allergic Alveolitis Chest, January 1, 2005; 127(1): 251 - 256. [Abstract] [Full Text] [PDF]

				D. A. Culver, B. P. Barna, B. Raychaudhuri, T. L. Bonfield, S. Abraham, A. Malur, C. F. Farver, M. S. Kavuru, and M. J. Thomassen Peroxisome Proliferator-Activated Receptor {gamma} Activity Is Deficient in Alveolar Macrophages in Pulmonary Sarcoidosis Am. J. Respir. Cell Mol. Biol., January 1, 2004; 30(1): 1 - 5. [Abstract] [Full Text] [PDF]

				K. Yokomura, T. Suda, S. Sasaki, N. Inui, K. Chida, and H. Nakamura Increased Expression of the 25-Hydroxyvitamin D3-1{alpha}-Hydroxylase Gene in Alveolar Macrophages of Patients with Lung Cancer J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5704 - 5709. [Abstract] [Full Text] [PDF]

				Z. Tong, H. Dai, B. Chen, Z. Abdoh, J. Guzman, and U. Costabel Inhibition of Cytokine Release From Alveolar Macrophages in Pulmonary Sarcoidosis by Pentoxifylline: Comparison With Dexamethasone Chest, October 1, 2003; 124(4): 1526 - 1532. [Abstract] [Full Text] [PDF]

				H-P Hauber, D Gholami, A Meyer, and A Pforte Increased interleukin-13 expression in patients with sarcoidosis Thorax, June 1, 2003; 58(6): 519 - 524. [Abstract] [Full Text] [PDF]

				U. Costabel Sarcoidosis: clinical update Eur. Respir. J., July 1, 2001; 18(32_suppl): 56S - 68s. [Abstract] [Full Text] [PDF]

				M Möllers, S P Aries, D Drömann, B Mascher, J Braun, and K Dalhoff Intracellular cytokine repertoire in different T cell subsets from patients with sarcoidosis Thorax, June 1, 2001; 56(6): 487 - 493. [Abstract] [Full Text]

				E. Yamaguchi, A. Itoh, N. Hizawa, and Y. Kawakami The Gene Polymorphism of Tumor Necrosis Factor-{beta}, But Not That of Tumor Necrosis Factor-{{alpha}}, Is Associated With the Prognosis of Sarcoidosis Chest, March 1, 2001; 119(3): 753 - 761. [Abstract] [Full Text] [PDF]

				K. Shigehara, N. Shijubo, M. Ohmichi, R. Takahashi, S.-i. Kon, H. Okamura, M. Kurimoto, Y. Hiraga, T. Tatsuno, S. Abe, et al. IL-12 and IL-18 Are Increased and Stimulate IFN-{{gamma}} Production in Sarcoid Lungs J. Immunol., January 1, 2001; 166(1): 642 - 649. [Abstract] [Full Text] [PDF]

				C. M. Greene, G. Meachery, C. C. Taggart, C. P. Rooney, R. Coakley, S. J. O'Neill, and N. G. McElvaney Role of IL-18 in CD4+ T Lymphocyte Activation in Sarcoidosis J. Immunol., October 15, 2000; 165(8): 4718 - 4724. [Abstract] [Full Text] [PDF]

				R. A. TAHA, E. M. MINSHALL, R. OLIVENSTEIN, D. IHAKU, B. WALLAERT, A. TSICOPOULOS, A.-B. TONNEL, R. DAMIA, D. MENZIES, and Q. A. HAMID Increased Expression of IL-12 Receptor mRNA in Active Pulmonary Tuberculosis and Sarcoidosis Am. J. Respir. Crit. Care Med., October 1, 1999; 160(4): 1119 - 1123. [Abstract] [Full Text]